{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:48:20Z","timestamp":1791528500792,"version":"4.3.4"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,31]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To clarify the clinical characteristics of patients with ocular involvement in giant cell arteritis (GCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was an observational, single-centre, retrospective study of patients with GCA treated at Juntendo University Hospital between January 2012 and July 2023. The study involved 71 patients, including 21 with ocular involvement: 10 had fundus findings such as anterior ischemic optic neuropathy or central retinal artery occlusion (6 with permanent vision loss) and 11 without fundus findings. The demographic and clinical features of GCA were compared between patients with and without ocular involvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The temporal artery was found to be affected more frequently in cases with ocular involvement than in those without on positron emission tomography\/computed tomography (P\u2009=\u2009.013) and vascular ultrasound (P\u2009=\u2009.02). The average number of signs and symptoms observed before diagnosis was higher in patients with ocular involvement than in those without (P\u2009&amp;lt;\u2009.001). The period from the appearance of ocular involvement to therapy initiation was shorter in patients with fundus findings than in those without (8.2 vs. 73.8\u00a0days; P\u2009=\u2009.032).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Early imaging and early consultation with an ophthalmologist are important, as ocular involvement with fundus findings tended to occur earlier in GCA patients than without fundus findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/mr\/roag013","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:25:17Z","timestamp":1771331117000},"page":"794-800","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics of giant cell arteritis with ocular involvement: A single-centre retrospective study"],"prefix":"10.1093","volume":"36","author":[{"given":"Toshio","family":"Kawamoto","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Ogasawara","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuko","family":"Nojiri","sequence":"additional","affiliation":[{"name":"Department of Medical Technology Innovation Centre, Juntendo University Faculty of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyuta","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Matsuki-Muramoto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3058-5778","authenticated-orcid":false,"given":"Masakazu","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0565-1828","authenticated-orcid":false,"given":"Ken","family":"Yamaji","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1729-2954","authenticated-orcid":false,"given":"Naoto","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"2026083106415540100_ref1","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nrrheum.2017.98","article-title":"Visual loss and other cranial ischaemic complications in giant cell arteritis","volume":"13","author":"Soriano","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"2026083106415540100_ref2","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0161-6420(94)31102-X","article-title":"Visual morbidity in giant cell arteritis: clinical characteristics and prognosis for vision","volume":"101","author":"Liu","year":"1994","journal-title":"Ophthalmology"},{"key":"2026083106415540100_ref3","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1093\/rheumatology\/keq039a","article-title":"BSR and BHPR guidelines for the management of giant cell arteritis","volume":"49","author":"Dasgupta","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2026083106415540100_ref4","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/ICU.0b013e32833eae8b","article-title":"Diagnosis and management of giant cell arteritis: a review","volume":"21","author":"Kale","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"key":"2026083106415540100_ref5","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1007\/s00296-013-2814-0","article-title":"Characteristics of cerebrovascular accidents at time of diagnosis in a series of 98 patients with giant cell arteritis","volume":"33","author":"Zenone","year":"2013","journal-title":"Rheumatol Int"},{"key":"2026083106415540100_ref6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/rheumatology\/kev262","article-title":"Increased risk of cardiovascular disease in giant cell arteritis: a general population-based study","volume":"55","author":"Amiri","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"2026083106415540100_ref7","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1056\/NEJMra1413352","article-title":"Ischemic optic neuropathies","volume":"372","author":"Biousse","year":"2015","journal-title":"N Engl J Med"},{"key":"2026083106415540100_ref8","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1136\/ard-2022-223480","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis","volume":"81","author":"Ponte","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2026083106415540100_ref9","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/art.40864","article-title":"Diagnostic accuracy of positron emission tomography\/computed tomography of the head, neck, and chest for giant cell arteritis: a prospective, double-blind, cross-sectional study","volume":"71","author":"Sammel","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2026083106415540100_ref10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/01.md.0000145369.25558.b5","article-title":"Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis","volume":"83","author":"Gonzalez-Gay","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"2026083106415540100_ref11","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s00296-019-04422-5","article-title":"Characteristics of patients with giant cell arteritis who experience visual symptoms","volume":"39","author":"Chean","year":"2019","journal-title":"Rheumatol Int"},{"key":"2026083106415540100_ref12","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1007\/s10067-021-05643-5","article-title":"Characterization of visual manifestations and identification of risk factors for permanent vision loss in patients with giant cell arteritis","volume":"40","author":"Baalbaki","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2026083106415540100_ref13","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/rheumatology\/keae042","article-title":"Visual manifestations in giant cell arteritis: identification of risk factors from the ARTESER registry","volume":"64","author":"Molina-Collada","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026083106415540100_ref14","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.3899\/jrheum.151033","article-title":"Visual complications in patients with biopsy-proven giant cell arteritis: a population-based study","volume":"43","author":"Saleh","year":"2016","journal-title":"J Rheumatol"},{"key":"2026083106415540100_ref15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.semarthrit.2019.09.008","article-title":"Characteristics and outcomes of patients with ophthalmologic involvement in giant cell arteritis: a case-control study","volume":"50","author":"Dumont","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2026083106415540100_ref16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13075-020-02171-6","article-title":"Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions","volume":"22","author":"Sugihara","year":"2020","journal-title":"Arthritis Res Ther"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mr\/advance-article-pdf\/doi\/10.1093\/mr\/roag013\/66994675\/roag013.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/36\/5\/794\/66994675\/roag013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/36\/5\/794\/66994675\/roag013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:42:06Z","timestamp":1788172926000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/36\/5\/794\/8490865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":16,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,2,20]]},"published-print":{"date-parts":[[2026,8,31]]}},"URL":"https:\/\/doi.org\/10.1093\/mr\/roag013","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,2,20]]}}}